
- Volume 0 0
FDA APPROVES FIRST GENERIC ONDANSETRON
The FDA recently approved thefirst generic versions of Zofran(ondansetron) Injection and Zofran(ondansetron) InjectionPremixed, drugs used to preventnausea and vomiting in chemotherapypatients.
Indicating that Zofran rankedamong the 20 most expensivebrand name drugs used in UShospitals during 2005, FDAGeneric Drug Office DirectorGary J. Buehler predicted thatthe approvals "will result in significantsavings for the Americanpublic."
According to the FDA, ondansetroninjection is packagedin single (4 mg/2 mL) and multidose(40 mg/20 mL) vials madeby Teva Pharmaceuticals USA.Ondansetron Injection Premixed,32 mg/50 mL in 5% dextrose, ismade by SICOR PharmaceuticalsInc. GlaxoSmithKline, maker ofthe innovator drug, has agreedto waive the remainder of a 6-month exclusivity period.
Articles in this issue
almost 20 years ago
Preventing Rasagiline Drug Interactionsalmost 20 years ago
nacds SPEAKS OUT: Specialty Pharmaceuticals on the Risealmost 20 years ago
Strategies for Coping with Alzheimer's Diseasealmost 20 years ago
Captive at the Counter: When Robbers Take Hostages—Part 1almost 20 years ago
A Third Category? Medicines Go Behind the Counteralmost 20 years ago
Avoiding Common Dispensing Errorsalmost 20 years ago
Pharm School Receives Grant to Help with Part Dalmost 20 years ago
compounding HOTLINEalmost 20 years ago
The Pharmacist's Role in the Management of Alzheimer's Diseasealmost 20 years ago
A Challenging Path to a PharmD DegreeRelated to this article








